| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 7 |
| 1 | NIVOLUMAB | 6 |
| 2 | TACROLIMUS | 6 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 4 | TACROLIMUS OINTMENT 0.1% | 6 |
| 5 | MYCOPHENOLATE MOFETIL | 5 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 5 |
| 7 | DAPTOMYCIN | 4 |
| 8 | IPILIMUMAB | 4 |
| 9 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM-BMEZ | 1 | 0.0016 |
| 1 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 2 | MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN | 1 | 0.0005 |
| 3 | ZINC OXIDE OINTMENT | 1 | 0.0005 |
| 4 | ZINC OXIDE | 1 | 0.0005 |
| 5 | DAPTOMYCIN | 4 | 0.0004 |
| 6 | DOSTARLIMAB | 1 | 0.0004 |
| 7 | SKIN PROTECTANT | 1 | 0.0004 |
| 8 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 9 | BINIMETINIB | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipopeptide Antibacterial [EPC] | 4 | 0.0004 |
| 1 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 14 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |